Terms: = Gastric cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Treatment
6 results:
1. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
2. Gastrin promotes the metastasis of gastric carcinoma through the β-catenin/tcf-4 pathway.
Zhuang K; Yan Y; Zhang X; Zhang J; Zhang L; Han K
Oncol Rep; 2016 Sep; 36(3):1369-76. PubMed ID: 27430592
[TBL] [Abstract] [Full Text] [Related]
3. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract] [Full Text] [Related]
4. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression.
Kim SJ; Choi IJ; Cheong TC; Lee SJ; Lotan R; Park SH; Chun KH
Gastroenterology; 2010 Mar; 138(3):1035-45.e1-2. PubMed ID: 19818782
[TBL] [Abstract] [Full Text] [Related]
5. Peroxisome proliferator-activated receptor delta and gastric cancer (Review).
Wu CW; Yu J; Sung JJ
Oncol Rep; 2009 Sep; 22(3):451-7. PubMed ID: 19639188
[TBL] [Abstract] [Full Text] [Related]
6. Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell.
Lee JH; Park CH; Jung KC; Rhee HS; Yang CH
Biochem Biophys Res Commun; 2005 Sep; 335(3):771-6. PubMed ID: 16102728
[TBL] [Abstract] [Full Text] [Related]
